“…Gait impairment is highly prevalent in multiple sclerosis (MS), as the decline on neural control affects motor functions, and consequently gait, balance and mobility (Kamm, Uitdehaag, & Polman, 2014;Kurtzke, 1983). Objective gait measurements enable the assessment of the quality and performance of gait, including gait variability and asymmetry (Lord, Galna, & Rochester, 2013), providing important information to complete the neurological evaluation of persons with MS (Frechette et al, 2019;Vienne-Jumeau, Quijoux, Vidal, & Ricard, 2019). Objective gait assessments are high sensitive to changes in symptoms, supporting early diagnosis and the evaluation of therapeutic interventions (Hubble, Naughton, Silburn, & Cole, 2015;Spain et al, 2012).…”